CD8A and cancer: In fact, ICD alters TAA expression from dying cancer cells, alerting the immune system, and this process activates T lymphocytes, particularly CD8+ cytotoxic T cells, which play a key role in attacking cancer cells through cytokine production such as IFN-γ (33, 34).